6 October 2021 - In early July, science journalist Kai Kupferschmidt spoke with the co-founders of BioNTech Özlem Türeci and Ugur Sahin. Kai spoke with them about their journey from physician scientists to entrepreneurs and how BioNTech, a company with a strong focus on cancer developed the first approved Covid-19 vaccine in less than one year. Türeci and Sahin were elected EMBO Members in 2021. 

6 October 2021 - In early July, science journalist Kai Kupferschmidt spoke with the co-founders of BioNTech Özlem Türeci and Ugur Sahin. Kai spoke with them about their journey from physician scientists to entrepreneurs and how BioNTech, a company with a strong focus on cancer developed the first approved Covid-19 vaccine in less than one year. Türeci and Sahin were elected EMBO Members in 2021.

6 October 2021 - In early July,&nbsp;science journalist Kai Kupferschmidt spoke with the co-founders of BioNTech&nbsp;Özlem&nbsp;Türeci and&nbsp;Ugur Sahin.&nbsp;Kai spoke with them about their journey from physician scientists to entrepreneurs and how BioNTech, a company with a strong focus on cancer developed the first&nbsp;approved&nbsp;Covid-19 vaccine in less than one year. Türeci and Sahin were elected EMBO&nbsp;Members in 2021.&nbsp;

Share Baptism by fire

Sign up to save your podcasts

Baptism by fire

Baptism by fire